Compumedics Limited Price Chart
Compumedics Limited CMP.XA Financial and Trading Overview
| Compumedics Limited stock price | 0.26 AUD |
| Previous Close | 0.19 AUD |
| Open | 0.2 AUD |
| Bid | 0.17 AUD x N/A |
| Ask | 0.19 AUD x N/A |
| Day's Range | 0.19 - 0.2 AUD |
| 52 Week Range | 0.14 - 0.31 AUD |
| Volume | 20.44K AUD |
| Avg. Volume | 12.44K AUD |
| Market Cap | N/A |
| Beta (5Y Monthly) | 0.984674 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 AUD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
CMP.XA Valuation Measures
| Enterprise Value | 36.92M AUD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 1.9473685 |
| Enterprise Value/Revenue | 0.919 |
| Enterprise Value/EBITDA | -4.896 |
Trading Information
Compumedics Limited Stock Price History
| Beta (5Y Monthly) | 0.984674 |
| 52-Week Change | 12.12% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.31 AUD |
| 52 Week Low | 0.14 AUD |
| 50-Day Moving Average | 0.19 AUD |
| 200-Day Moving Average | 0.2 AUD |
CMP.XA Share Statistics
| Avg. Volume (3 month) | 12.44K AUD |
| Avg. Daily Volume (10-Days) | 12.47K AUD |
| Shares Outstanding | N/A |
| Float | 48.55M |
| Short Ratio | N/A |
| % Held by Insiders | 71.71% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | June 30, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | June 30, 2023 |
Profitability
| Profit Margin | -15.28% |
| Operating Margin (ttm) | -19.84% |
| Gross Margin | 50.57% |
| EBITDA Margin | -18.76% |
Management Effectiveness
| Return on Assets (ttm) | -12.56% |
| Return on Equity (ttm) | -31.29% |
Income Statement
| Revenue (ttm) | 40.18M AUD |
| Revenue Per Share (ttm) | 0.21 AUD |
| Quarterly Revenue Growth (yoy) | 14.49% |
| Gross Profit (ttm) | 19.32M AUD |
| EBITDA | -7541000 AUD |
| Net Income Avi to Common (ttm) | -6143000 AUD |
| Diluted EPS (ttm) | 0 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 5.67M AUD |
| Total Cash Per Share (mrq) | 0.03 AUD |
| Total Debt (mrq) | 9.81M AUD |
| Total Debt/Equity (mrq) | 58.39 AUD |
| Current Ratio (mrq) | 1.373 |
| Book Value Per Share (mrq) | 0.095 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 1.54M AUD |
| Levered Free Cash Flow (ttm) | -1560750 AUD |
Profile of Compumedics Limited
| Country | Australia |
| State | VIC |
| City | Abbotsford |
| Address | 30-40 Flockhart Street |
| ZIP | 3067 |
| Phone | 61 3 8420 7300 |
| Website | https://www.compumedics.com.au |
| Industry | |
| Sector(s) | |
| Full Time Employees | 135 |
Compumedics Limited researches, develops, manufactures, sells, and distributes medical devices in Australia, the Asia Pacific, the Americas, Europe, and the Middle East. It provides sleep diagnostics products, including Grael 4K PSG:EEG amplifiers; Somté PSG; Siesta 802, an ambulatory recording device; Okti; Grael PSG; Grael DC; Somfit/Somfit Pro, a wearable device; TCM5 FLEX Transcutaneous monitor; and Somté, an investigative tool. The company also provides neurology diagnostics, such as ONsight A.V.S. for monitoring patient's home ambulatory studies; Grael 4K PSG:EEG amplifiers; Grael 4K-EEG amplifiers; Grael LT EEG System amplifiers; Neuvo 64-512 Channel LTM EEG monitoring systems; Xegis Forte EMG/EP; and Xegis G:NEO 2 Channel EMG/EP systems. In addition, it offers software products, such as Profusion Sleep software suite; Profusion EEG Software; Profusion neXus 360, a web-based patient data and lab management system that provides integrated hardware and software solutions for sleep and neurology clinics; Multi-Modal Neuroimaging Suite; Profusion neXus Laboratory Management System to optimize administrative and operational workflow needs of diagnostic and research laboratories; Profusion neXus Scheduler for planning for staff and time; and HD Digital Video, a plug-in software module to add synchronized digital video capabilities to sleep and EEG systems, as well as ECG Free, Profusion Plus, Siesta extended battery pack, summit IP, and persyst software products. Further, the company provides magnetoencephalography systems; brain research technologies; pharmaceutical clinical trials and research services; accessories; and a range of consumables and supplies for diagnostic and research solutions. The company was incorporated in 1987 and is headquartered in Abbotsford, Australia. Compumedics Limited operates as a subsidiary of D & DJ Burton Holdings Pty Ltd.
Q&A For Compumedics Limited Stock
What is a current CMP.XA stock price?
Compumedics Limited CMP.XA stock price today per share is 0.26 AUD.
How to purchase Compumedics Limited stock?
You can buy CMP.XA shares on the Cboe AU exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Compumedics Limited?
The stock symbol or ticker of Compumedics Limited is CMP.XA.
How many shares does Compumedics Limited have in circulation?
The max supply of Compumedics Limited shares is 0.
What is Compumedics Limited Price to Earnings Ratio (PE Ratio)?
Compumedics Limited PE Ratio is now.
What was Compumedics Limited earnings per share over the trailing 12 months (TTM)?
Compumedics Limited EPS is 0 AUD over the trailing 12 months.